PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections

View source ↗

Summary

The EMA's safety committee (PRAC) has opened a safety review of levamisole, used to treat parasitic worm infections, to evaluate the potential risk of leukoence…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminthiasis

Drugs mentioned

• Levamisole (levamisole)

Snippet

Review will assess risk of leukoencephalopathy, a condition affecting the brain